# Heart Failure Management for Patient With CIED Remotely Monitored

Study · id `cardio:ct-nct07247032` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07247032](<https://clinicaltrials.gov/study/NCT07247032>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07247032

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1132 participants.

## Technical summary

Registry record NCT07247032. Randomized; no masking; primary purpose prevention. Start 2025-12-19 (actual); primary completion 2027-05 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 1132 participants (planned count; ClinicalTrials.gov record NCT07247032, source copy `cardio:ctgov-nct07247032-2026-03-31`, retrieved 2026-10-26)
- Started: 2025-12-19 (actual) (ClinicalTrials.gov record NCT07247032, source copy `cardio:ctgov-nct07247032-2026-03-31`, retrieved 2026-10-26)
- Primary completion: 2027-05 (anticipated) (ClinicalTrials.gov record NCT07247032, source copy `cardio:ctgov-nct07247032-2026-03-31`, retrieved 2026-10-26)
- Completion: 2027-05 (anticipated) (ClinicalTrials.gov record NCT07247032, source copy `cardio:ctgov-nct07247032-2026-03-31`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT07247032, source copy `cardio:ctgov-nct07247032-2026-03-31`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07247032-2026-03-31`, retrieved 2026-10-26)

## The registry's words

- Brief title: Heart Failure Management for Patient With CIED Remotely Monitored
- Acronym: PROACT-HF
- Condition: Heart Failure
- Condition: Heart Failure NYHA Class II
- Condition: Heart Failure NYHA Class III
- Condition: Heart Failure With Reduced Ejection Fraction (HFrEF)
- Condition: Heart Failure With Decompensation
- Condition: CRT and/or ICD
- Intervention (Device): SmartSignalHF
- Intervention (Device): HF RM standard of care
- Lead sponsor: Implicity
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition term reads as this condition, and the trial is coded with its broader condition: Heart failure with reduced ejection fraction (HFrEF) (`cardio:hfref`)

## Provenance

Content hash: 584ee2229b0764b24b33a30a3de1ea8f1b4e11aa3e8f9d838e01f0b067bf19b0
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
